Griffith and China Grand Pharma sign landmark deal to develop new drug for parainfluenza virus
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.